Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Letsch

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
European Journal of Immunology|September 19, 2014
Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacityRobert F Kudernatsch, Anne Letsch, Manuel Guerreiro, et al.
International Journal of Cancer|January 13, 2005
Peptide vaccination after repeated resection of metastases can induce a prolonged relapse-free interval in melanoma patientsAnne Letsch, Ulrich Keilholz, Michael Fluck, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2025
Hämatrain-Hybrid movement therapy during inpatient and outpatient hematological treatment: correlations with physical and psychological parametersJohanna Huesmann, Anne Letsch, Lars Fransecky, et al.
Psycho-Oncology|November 13, 2019
Cancer patients' expectations when undergoing extensive molecular diagnostics-A qualitative studyAmy Rohrmoser, Theresia Pichler, Anne Letsch, et al.
Cancer Medicine|April 22, 2026
Sarcopenia in Oncological Patients Diagnostics, Screening, and Impact on Quality of Life, Fatigue, Handgrip Strength, and Physical Activity (Sarco-Detect Study)Friederike Hilpert, Lisa Jochem, Lea Feline Kraack, et al.
In Vivo (Athens, Greece)|April 28, 2026
Bioelectrical Impedance Analysis in the Diagnosis of Sarcopenia in Oncological Patients: The Sarco-Detect StudyLisa Jochem, Thore Wulff, Lea Feline Kraack, et al.
Clinical & Experimental Metastasis|March 23, 2013
Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells?Antonia Busse, Anne Letsch, Alberto Fusi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 16, 2025
Impact of adjuvant therapy on outcomes of cancer of the stomach and gastroesophageal junction in the real-worldSteffen M Heckl, Hans-Michael Behrens, Ulrike Ebert, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
"Wilms Tumor Protein 1" (WT1) peptide vaccination-induced complete remission in a patient with acute myeloid leukemia is accompanied by the emergence of a predominant T-cell clone both in blood and bone marrowSebastian Ochsenreither, Alberto Fusi, Antonia Busse, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2006
Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cellsIl-Kang Na, Ulrich Keilholz, Anne Letsch, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Immunology|September 19, 2014
Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacityRobert F Kudernatsch, Anne Letsch, Manuel Guerreiro, et al.
International Journal of Cancer|January 13, 2005
Peptide vaccination after repeated resection of metastases can induce a prolonged relapse-free interval in melanoma patientsAnne Letsch, Ulrich Keilholz, Michael Fluck, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 13, 2025
Hämatrain-Hybrid movement therapy during inpatient and outpatient hematological treatment: correlations with physical and psychological parametersJohanna Huesmann, Anne Letsch, Lars Fransecky, et al.
Psycho-Oncology|November 13, 2019
Cancer patients' expectations when undergoing extensive molecular diagnostics-A qualitative studyAmy Rohrmoser, Theresia Pichler, Anne Letsch, et al.
Cancer Medicine|April 22, 2026
Sarcopenia in Oncological Patients Diagnostics, Screening, and Impact on Quality of Life, Fatigue, Handgrip Strength, and Physical Activity (Sarco-Detect Study)Friederike Hilpert, Lisa Jochem, Lea Feline Kraack, et al.
In Vivo (Athens, Greece)|April 28, 2026
Bioelectrical Impedance Analysis in the Diagnosis of Sarcopenia in Oncological Patients: The Sarco-Detect StudyLisa Jochem, Thore Wulff, Lea Feline Kraack, et al.
Clinical & Experimental Metastasis|March 23, 2013
Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells?Antonia Busse, Anne Letsch, Alberto Fusi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 16, 2025
Impact of adjuvant therapy on outcomes of cancer of the stomach and gastroesophageal junction in the real-worldSteffen M Heckl, Hans-Michael Behrens, Ulrike Ebert, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2010
"Wilms Tumor Protein 1" (WT1) peptide vaccination-induced complete remission in a patient with acute myeloid leukemia is accompanied by the emergence of a predominant T-cell clone both in blood and bone marrowSebastian Ochsenreither, Alberto Fusi, Antonia Busse, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2006
Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cellsIl-Kang Na, Ulrich Keilholz, Anne Letsch, et al.
Pageof 9